| Estrogen receptor alpha (ESR1) gene amplification is frequent in breast cancer F Holst, PR Stahl, C Ruiz, O Hellwinkel, Z Jehan, M Wendland, A Lebeau, ... Nature genetics 39 (5), 655-660, 2007 | 496 | 2007 |
| Clinicopathological Analysis of Papillary Thyroid Cancer with PIK3CA Alterations in a Middle Eastern Population J Abubaker, Z Jehan, P Bavi, M Sultana, S Al-Harbi, M Ibrahim, ... The Journal of Clinical Endocrinology & Metabolism 93 (2), 611-618, 2008 | 228 | 2008 |
| Genome-wide expression analysis of Middle Eastern colorectal cancer reveals FOXM1 as a novel target for cancer therapy S Uddin, M Ahmed, A Hussain, J Abubaker, N Al-Sanea, A AbdulJabbar, ... The American journal of pathology 178 (2), 537-547, 2011 | 187 | 2011 |
| FoxM1 and its association with matrix metalloproteinases (MMP) signaling pathway in papillary thyroid carcinoma M Ahmed, S Uddin, AR Hussain, A Alyan, Z Jehan, F Al-Dayel, ... The Journal of Clinical Endocrinology & Metabolism 97 (1), E1-E13, 2012 | 81 | 2012 |
| Bortezomib stabilizes mitotic cyclins and prevents cell cycle progression via inhibition of UBE2C in colorectal carcinoma P Bavi, S Uddin, M Ahmed, Z Jehan, R Bu, J Abubaker, M Sultana, ... The American journal of pathology 178 (5), 2109-2120, 2011 | 76 | 2011 |
| Genome‐wide expression analysis of Middle Eastern papillary thyroid cancer reveals c‐MET as a novel target for cancer therapy AK Siraj, P Bavi, J Abubaker, Z Jehan, M Sultana, F Al‐Dayel, A Al‐Nuaim, ... The Journal of pathology 213 (2), 190-199, 2007 | 68 | 2007 |
| Frequent PIK3CA gene amplification and its clinical significance in colorectal cancer Z Jehan, P Bavi, M Sultana, J Abubaker, R Bu, A Hussain, G Alsbeih, ... The Journal of Pathology: A Journal of the Pathological Society of Great …, 2009 | 66 | 2009 |
| Loss of PTEN expression is associated with aggressive behavior and poor prognosis in Middle Eastern triple-negative breast cancer S Beg, AK Siraj, S Prabhakaran, Z Jehan, D Ajarim, F Al-Dayel, A Tulbah, ... Breast Cancer Research and Treatment 151, 541-553, 2015 | 57 | 2015 |
| PIK3CA alterations in Middle Eastern ovarian cancers J Abubaker, P Bavi, W Al-Haqawi, Z Jehan, A Munkarah, S Uddin, ... Molecular Cancer 8, 1-12, 2009 | 55 | 2009 |
| ALK alteration is a frequent event in aggressive breast cancers AK Siraj, S Beg, Z Jehan, S Prabhakaran, M Ahmed, A R. Hussain, ... Breast Cancer Research 17, 1-12, 2015 | 50 | 2015 |
| Prevalence of fragile histidine triad expression in tumors from Saudi Arabia: a tissue microarray analysis P Bavi, Z Jehan, V Atizado, H Al-Dossari, F Al-Dayel, A Tulbah, SS Amr, ... Cancer Epidemiology Biomarkers & Prevention 15 (9), 1708-1718, 2006 | 50 | 2006 |
| PTEN loss is associated with follicular variant of Middle Eastern papillary thyroid carcinoma S Beg, AK Siraj, Z Jehan, S Prabakaran, SS Al-Sobhi, M Al-Dawish, ... British journal of cancer 112 (12), 1938-1943, 2015 | 43 | 2015 |
| ALK gene amplification is associated with poor prognosis in colorectal carcinoma P Bavi, Z Jehan, R Bu, S Prabhakaran, N Al-Sanea, F Al-Dayel, ... British journal of cancer 109 (10), 2735-2743, 2013 | 42 | 2013 |
| Overexpression of fatty acid synthase in Middle Eastern epithelial ovarian carcinoma activates AKT and Its inhibition potentiates cisplatin-induced apoptosis S Uddin, Z Jehan, M Ahmed, A Alyan, F Al-Dayel, A Hussain, P Bavi, ... Molecular Medicine 17, 635-645, 2011 | 38 | 2011 |
| Role of X-linked inhibitor of apoptosis as a prognostic marker and therapeutic target in papillary thyroid carcinoma AR Hussain, R Bu, M Ahmed, Z Jehan, S Beg, S Al-Sobhi, F Al-Dayel, ... The Journal of Clinical Endocrinology & Metabolism 100 (7), E974-E985, 2015 | 37 | 2015 |
| In-situ hybridization as a molecular tool in cancer diagnosis and treatment Z Jehan, S Uddin, K S Al-Kuraya Current medicinal chemistry 19 (22), 3730-3738, 2012 | 37 | 2012 |
| Bortezomib-mediated expression of p27Kip1 through S-phase kinase protein 2 degradation in epithelial ovarian cancer S Uddin, M Ahmed, AR Hussain, Z Jehan, F Al-Dayel, A Munkarah, P Bavi, ... Laboratory investigation 89 (10), 1115-1127, 2009 | 29 | 2009 |
| Genetic polymorphisms of methylenetetrahydrofolate reductase and promoter methylation of MGMT and FHIT genes in diffuse large B cell lymphoma risk in Middle East AK Siraj, M Ibrahim, M Al-Rasheed, R Bu, P Bavi, Z Jehan, J Abubaker, ... Annals of hematology 86, 887-895, 2007 | 25 | 2007 |
| Role of nuclear factor-κB regulators TNFAIP3 and CARD11 in Middle Eastern diffuse large B-cell lymphoma R Bu, P Bavi, J Abubaker, Z Jehan, W Al-Haqawi, D Ajarim, F Al-Dayel, ... Leukemia & lymphoma 53 (10), 1971-1977, 2012 | 23 | 2012 |
| Distinct gene expression profiles: nodal versus extranodal diffuse large B-cell lymphoma Z Jehan, AK Siraj, J Abubaker, C Ruiz, R Simon, M Sultana, S Uddin, ... Oncology 75 (1-2), 71-80, 2008 | 20 | 2008 |
Shahab Uddin, PhDSenior Scientist Hamad Medical CorporationEmail yang diverifikasi di hamad.qa